462 related articles for article (PubMed ID: 18289808)
1. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
6. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
7. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
[TBL] [Abstract][Full Text] [Related]
8. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
11. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
12. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
Qian F; Cui F; Ding J; Tang C; Yin C
Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
[TBL] [Abstract][Full Text] [Related]
13. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
14. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
15. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
16. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
19. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]